Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

NCT02724618 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Curcumin
RADIATION: RT
DRUG: Placebo

Sponsor

Shahid Beheshti University of Medical Sciences

Collaborators

[object Object]